Patent · US Active

Diacylglycerol acyltransferase 2 inhibitors

US9440949B2 · kind B2 · utility

3Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2015
Grant dateSep 13, 2016
Priority date
Expiry dateMar 10, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.